Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Aug 07, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001969223-24-000573.pdf
Aug 07, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-24-000043.pdf 0001883850-24-000043.xls
Aug 06, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000113.pdf 0001968202-24-000113.xls
Aug 05, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000111.pdf 0001968202-24-000111.xls
Aug 05, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000110.pdf 0001968202-24-000110.xls
Aug 05, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-24-000041.pdf 0001883850-24-000041.xls
Aug 05, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-24-000040.pdf 0001883850-24-000040.xls
Aug 02, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001000275-24-000055.pdf 0001000275-24-000055.xls
Aug 01, 2024	8-K	Report of unscheduled material events or corporate event	View HTML 0001804220-24-000026.pdf 0001804220-24-000026.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Aug 01, 2024	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0001804220-24-000028.pdf 0001804220-24-000028.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA

Data provided by Kaleidoscope.

Investors & Media